The Use of Stimulant Medication to Treat Neurocognitive Deficits in Patients with Pediatric Cancer, Traumatic Brain Injury, and Sickle Cell Disease: A Review-Reference-Cited by-同舟云学术

The Use of Stimulant Medication to Treat Neurocognitive Deficits in Patients with Pediatric Cancer, Traumatic Brain Injury, and Sickle Cell Disease: A Review

Published:2012-09 Issue:5 Volume:124 Page:78-90
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Nicholls Elizabeth,Hildenbrand Aimee K.,Aggarwal Richa,McCarthy Lauren,Daly Brian

Publisher

Informa UK Limited

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3810/pgm.2012.09.2596

Reference97 articles.

1. Preventing Neurocognitive Late Effects in Childhood Cancer Survivors

2. Outcome and Predictors of Functional Recovery 5 Years Following Pediatric Traumatic Brain Injury (TBI)

3. Cognitive and academic problems associated with childhood cancers and sickle cell disease.

4. Folate Pathway Genetic Polymorphisms are Related to Attention Disorders in Childhood Leukemia Survivors

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbid ADHD and Pediatric Sickle Cell Disease: Prevalence and Risk Factors;Journal of Clinical Psychology in Medical Settings;2024-07-09

2. Barriers to the use of Methylphenidate in Pediatric Neuro-oncology Services;Cognitive and Behavioral Neurology;2023-09-19

3. Hypersomnias in children;Encyclopedia of Sleep and Circadian Rhythms;2023

4. The influence of methylphenidate on sustained attention in paediatric acquired brain injury: a meta-analytical review;Child Neuropsychology;2022-08-24

5. Effectively Supporting Youth with Chronic Illness in Schools;Pediatric Clinics of North America;2022-08